Posttransplantation cutaneous B-cell lymphoma with monoclonal epstein- barr virus infection, responding to acyclovir and reduction in immunosuppression

N. Mozzanica, A. Cattaneo, N. Fracchiolla, V. Boneschi, E. Berti, E. Gronda, M. Mangiavacchi, A. F. Finzi, A. Neri

Research output: Contribution to journalArticle


Posttransplantation lymphoproliferative disorders (PTLDs) represent an important complication of solid organ transplantation. The main causative factor of PTLDs seems to be the intensity and type of immunosuppressive therapy and the frequent occurrence of Epstein-Barr virus infection. PTLDs that are disseminated at diagnosis or present late after transplantation generally share an unfavorable prognosis and are unlikely to regress in response to reduction in immunosuppressive therapy. We describe a case of cutaneous B-cell lymphoma occurring 4 years after heart transplantation in which molecular analysis revealed a monoclonal pattern of Epstein-Barr virus infection and immunoglobulin gene rearrangement. In spite of its monoclonal nature and late occurrence, the lymphomatous lesions regressed completely after antiviral treatment and a reduction in immunosuppressive therapy.

Original languageEnglish
Pages (from-to)964-968
Number of pages5
JournalJournal of Heart and Lung Transplantation
Issue number9
Publication statusPublished - 1997


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this